This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Strict or Liberal Insulin Protocol Following Coronary Artery Bypass Graft (CABG) Surgery

Sponsored by Inova Health Care Services

About this trial

Last updated 4 years ago

Study ID

SLIP - 09.111

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Trial Timing

Ended 9 years ago

What is this trial about?

This research study is designed to better understand post-operative complications as related to the tightness of blood sugar control. It is also hoped that we may learn that a more liberal control of your blood sugars is not inferior to the current strict glucose control. Our ultimate goal is to evaluate if there is any change in the rates of complications between the two groups. We will be comparing the current strict blood glucose control with a more liberal target for blood sugars.

What are the participation requirements?

Yes

Inclusion Criteria

1. All diabetic patients going for isolated, non-emergent CABG surgery at Inova Fairfax Hospital (IFH).

2. Non diabetic patients going for isolated, non-emergent CABG Surgery at IFH that are found to have a finger stick blood glucose > 150 mg/dl, either pre-operative, during the procedure or post-operatively.

3. Those patients that meet Inclusion Criteria #1 OR #2 AND have been started on an insulin infusion while in the operative room will be enrolled.

No

Exclusion Criteria

1. Patients that are not undergoing CABG surgery.

2. Patients that post-CABG surgery are not on an insulin infusion.

3. Patients that are undergoing other procedures in addition to CABG will be excluded. (ie. CABG + valve repair)